The meeting will be held in conjunction with the 9th International Workshop on Clinical Pharmacology of HIV Therapy, with a joint session on Wednesday afternoon, April 9.
The objective of the workshop is to provide a forum for discussion of topics related to clinical pharmacology of current and future drugs in the treatment of viral hep B and hep C.
Topics that will be covered include preclinical models of hepatitis, genetic variation in host and virus, factors affecting treatment outcome, current and future drugs and their mechanism of action, and exposure-response (PK/PD) relationships.
The format of the meeting will consist of plenary presentations by invited speakers, abstract-driven presentations, poster viewing and Q&A-sessions.
We hope you will be able to join us in this important conference and look forward to seeing you in New Orleans.
The Organizing Committee:
David Beno (chair), Abbott Laboratories, USA
Charles Boucher (co-chair), University Medical Center Utrecht/ Department of Virology, Erasmus Medical Center, Rotterdam, the Netherlands
Lisa Benincosa, Pfizer, UK
Raffaele Bruno, University of Pavia, Italy
Charles Flexner, Johns Hopkins University, USA
Varun Garg, Vertex Pharmaceuticals, USA
John McHutchison, Duke Clinical Research Institute, USA
Jean-Michel Pawlotsky, Hôpital Henri Mondor, France
Steve Piscitelli, GlaxoSmithKline
Pratapa Prasad, Schering Plough USA
Ashok Radhit, Hoffmann-La Roche, USA
William Symonds, Pharmasset, USA
Xiao-Jian Zhou, Idenix Pharmaceuticals, USA